Taking immunogenicity, safety, and production capacity into account, the 320 U alum-adjuvant formulation of the EV71 vaccine is probably the best possible formulation for phase 3 trials.
Original Article: [Articles] Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial
Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.
Drugs Database search our comprehensive database of prescription drugs.
Research Literature - Daily Updated Database search biomedical papers and journals.
Search Biotech, Medical and Healthcare News
Popular Biotech, Medical and Healthcare News
Biotech News by Article Type
Biotech News by Location
Publishing Your News on BioPortfolio
Recent Visitor News Searches
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Consuming coffee linked to lower risk of an autoimmune liver disease
Automated BP Device Not Cutting It (CME/CE)
US psychiatry gets makeover in new manual
New case of SARS-like virus in Saudi: ministry
Feds Make It Easier For States To Enroll Poor Under Health Law
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
This site complies with the
HONcode standard for trustworthy health